Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0P6RT
|
|||
Former ID |
DIB019434
|
|||
Drug Name |
PMID8410973C3
|
|||
Synonyms |
GTPL8634; BDBM50008139; 137302-35-3
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL
|
|||
Formula |
C35H52F2N6O8S
|
|||
Canonical SMILES |
C=CCC(C(=O)NC(CC1CCCCC1)C(=O)C(C(=O)NCCN2CCOCC2)(F)F)NC(=O)C(CC3=CC=CC=C3)NS(=O)(=O)N4CCOCC4
|
|||
InChI |
1S/C35H52F2N6O8S/c1-2-9-28(39-33(46)30(25-27-12-7-4-8-13-27)41-52(48,49)43-18-22-51-23-19-43)32(45)40-29(24-26-10-5-3-6-11-26)31(44)35(36,37)34(47)38-14-15-42-16-20-50-21-17-42/h2,4,7-8,12-13,26,28-30,41H,1,3,5-6,9-11,14-25H2,(H,38,47)(H,39,46)(H,40,45)/t28-,29-,30-/m0/s1
|
|||
InChIKey |
MQDDTALXSBQTQP-DTXPUJKBSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Cathepsin D (CTSD) | Target Info | Inhibitor | [1] |
Cathepsin E (CTSE) | Target Info | Inhibitor | [1] | |
Pepsinogen-5 (PGA5) | Target Info | Inhibitor | [1] | |
Progastricsin pepsinogen C (PGC) | Target Info | Inhibitor | [1] | |
BioCyc | Thyroid hormone biosynthesis | |||
KEGG Pathway | Sphingolipid signaling pathway | |||
Lysosome | ||||
Tuberculosis | ||||
NetPath Pathway | IL2 Signaling Pathway | |||
Pathway Interaction Database | LKB1 signaling events | |||
Ceramide signaling pathway | ||||
Direct p53 effectors | ||||
Validated nuclear estrogen receptor alpha network | ||||
Reactome | Collagen degradation | |||
Metabolism of Angiotensinogen to Angiotensins | ||||
MHC class II antigen presentation |
References | Top | |||
---|---|---|---|---|
REF 1 | Specificity in the binding of inhibitors to the active site of human/primate aspartic proteinases: analysis of P2-P1-P1'-P2' variation. J Med Chem. 1993 Sep 3;36(18):2614-20. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.